CAS 1202896-51-2

Brivaracetam-d7

CAS : 1202896-51-2

Formule : C₁₁H₁₃D₇N₂O₂

Masse moléculaire : 219.34

Ref: 4Z-B-105064

Brivaracetam-d7

Produit contrôlé

CAS : 1202896-51-2

Applications Brivaracetam-d7, is the labeled analogue of Brivaracetam (B677645), which is a 4-n-propyl analog of levetiracetam (L331500), and a racetam derivative with anticonvulsant properties.
References Rosenstiel, P., et al.:Neurotherapeutics, 4 (1), 84 (2007);

Formule : C₁₁H₁₃D₇N₂O₂

Couleur et forme : Off White Solid

Masse moléculaire : 219.33

Ref: TR-B677647

Brivaracetam-d7

Produit contrôlé

CAS : 1202896-51-2

Brivaracetam-d7 is a drug product that is used for analytical purposes. It is a synthetic, high purity, HPLC standard with CAS No. 1202896-51-2. Brivaracetam-d7 has been shown to be pharmacologically active in the treatment of epilepsy and other CNS disorders. The natural form of brivaracetam-d7 is brivaracetam, which is an API impurity that occurs in the synthesis process. It can be synthesized from bromoacetic acid and 2-bromopropionic acid. The synthetic form of brivaracetam-d7 is manufactured through a custom synthesis process and does not contain any natural materials.

Formule : C₁₁H₂₀N₂O₂

Degré de pureté : Min. 95%

Masse moléculaire : 219.33 g/mol

Ref: 3D-IB181069